Integer Stock Forecast, Price & News

-0.85 (-0.91 %)
(As of 09/16/2021 11:36 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume648 shs
Average Volume149,921 shs
Market Capitalization$3.04 billion
P/E Ratio31.47
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ITGR News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

Integer logo

About Integer

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.23 out of 5 stars

Medical Sector

328th out of 1,352 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

6th out of 27 stocks

Analyst Opinion: 2.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Integer (NYSE:ITGR) Frequently Asked Questions

Is Integer a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Integer stock.
View analyst ratings for Integer
or view top-rated stocks.

What stocks does MarketBeat like better than Integer?

Wall Street analysts have given Integer a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Integer wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Integer's next earnings date?

Integer is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Integer

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) issued its quarterly earnings data on Thursday, July, 29th. The medical equipment provider reported $1.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.16. The medical equipment provider earned $312.02 million during the quarter, compared to the consensus estimate of $292.50 million. Integer had a trailing twelve-month return on equity of 8.46% and a net margin of 8.73%.
View Integer's earnings history

How has Integer's stock been impacted by COVID-19?

Integer's stock was trading at $79.33 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ITGR shares have increased by 16.2% and is now trading at $92.21.
View which stocks have been most impacted by COVID-19

What guidance has Integer issued on next quarter's earnings?

Integer issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $3.660-$4.030 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.820. The company issued revenue guidance of $1.20 billion-$1.22 billion, compared to the consensus revenue estimate of $1.19 billion.

What price target have analysts set for ITGR?

2 equities research analysts have issued 12 month price objectives for Integer's shares. Their forecasts range from $105.00 to $107.00. On average, they anticipate Integer's share price to reach $106.00 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price.
View analysts' price targets for Integer
or view top-rated stocks among Wall Street analysts.

Who are Integer's key executives?

Integer's management team includes the following people:
  • Joseph William Dziedzic, President, Chief Executive Officer & Director
  • Jennifer M. Bolt, Senior Vice President-Global Operations & ESG
  • Jason K. Garland, Chief Financial Officer & Executive Vice President
  • Elizabeth K. Giddens, Secretary, Chief Ethics & Compliance Officer
  • Kirk Thor, Chief Human Resources Officer & Executive VP

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer CEO Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among Integer's employees.

Who are some of Integer's key competitors?

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), The Procter & Gamble (PG), Gilead Sciences (GILD), The Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

What is Integer's stock symbol?

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Who are Integer's major shareholders?

Integer's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.58%), Vanguard Group Inc. (10.71%), Dimensional Fund Advisors LP (5.86%), Franklin Resources Inc. (5.39%), State Street Corp (3.65%) and Macquarie Group Ltd. (3.11%). Company insiders that own Integer stock include Anthony W Borowicz, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph W Dziedzic, Pamela G Bailey and Peter H Soderberg.
View institutional ownership trends for Integer

Which institutional investors are selling Integer stock?

ITGR stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Hawk Ridge Capital Management LP, William Blair Investment Management LLC, Goldman Sachs Group Inc., Fisher Asset Management LLC, RK Capital Management LLC, California Public Employees Retirement System, and BlackRock Inc.. Company insiders that have sold Integer company stock in the last year include Anthony W Borowicz, Bill R Sanford, Carter Houghton, and Jean M Hobby.
View insider buying and selling activity for Integer
or view top insider-selling stocks.

Which institutional investors are buying Integer stock?

ITGR stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., JPMorgan Chase & Co., Prudential Financial Inc., Morgan Stanley, Morgan Stanley, New York State Common Retirement Fund, Chartwell Investment Partners LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Integer
or or view top insider-buying stocks.

How do I buy shares of Integer?

Shares of ITGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integer's stock price today?

One share of ITGR stock can currently be purchased for approximately $92.21.

How much money does Integer make?

Integer has a market capitalization of $3.04 billion and generates $1.07 billion in revenue each year. The medical equipment provider earns $77.26 million in net income (profit) each year or $2.77 on an earnings per share basis.

How many employees does Integer have?

Integer employs 7,500 workers across the globe.

What is Integer's official website?

The official website for Integer is www.integer.net.

Where are Integer's headquarters?

Integer is headquartered at 5830 Granite Parkway Suite 1150, Plano TX, 75024.

How can I contact Integer?

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider can be reached via phone at (214) 618-5243 or via email at [email protected]

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.